Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

CBIO

CRESCENT BIOPHARMA, INC.

CIK 0001253689 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$16.76
↓ 0.05 (-0.30%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$462.11M
P/E Ratio
-2.64
EPS
Not covered
Dividend Yield
Not covered
52W Position
43%
Beta
0.65

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
2.51
P/S
38.89
EV/Revenue
22.97
ROE
-95.1%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 43%
$8.72$27.41

Latest Financials

2025-12-31 FY
Revenue
$10.84M
Net Income
-$153.94M
Total Assets
$240.29M
Free Cash Flow
-$72.45M

Recent news